SSSW(SH:688399) Shang Hai Zheng Quan Bao·2025-12-05 19:14Core Viewpoint - The announcement details the renewal of the "Consistent Action Agreement" among the actual controllers of Jiangsu Shuoshi Biotechnology Co., Ltd., aimed at ensuring stable governance and operational continuity of the company [1][2]. Group 1: Background of the Agreement - The actual controllers, Fang Yongsheng, Liang Xilin, and Wang Guoqiang, collectively control 27.53% and 3.81% of the company's shares through various partnerships, with Fang Yongsheng serving as the honorary chairman and Wang Guoqiang as the chairman and general manager [1][2]. - The agreement was initially signed before the company's IPO and has been renewed on December 5 for the years 2022, 2023, 2024, and now 2025 to promote stable development based on shared goals [2]. Group 2: Main Content of the Agreement - The parties agree to act consistently in decision-making regarding the company, maintaining alignment in exercising their shareholder rights and responsibilities [3][4]. - They commit to cooperating actively in significant company decisions and adhering to relevant legal obligations as consistent action persons [4]. - The agreement is effective for twelve months from the date of signing [5]. Group 3: Impact of the Agreement - The renewal of the agreement does not change the actual control of the company, which remains with Fang Yongsheng, Liang Xilin, and Wang Guoqiang, ensuring stability in control and continuity in strategic and operational policies [6].